🔸 BofA: UPGRADED to Buy from Neutral — PT $220
🔸 Morgan Stanley: Reiterates Overweight — PT $310
🔸 RBC Capital: Reiterates Outperform — PT $293
🔸 Citi: Raised to $182 from $180
🔸 Guggenheim: Raised to $126 from $122
🔸 Wedbush: Cut to $275 from $300
🔸 Canaccord Genuity: Cut to $222 from $234
🔸 Mizuho: Cut to $180 from $195
🔸 UBS: Cut to $147 from $160
🔸 Truist Securities: Cut to $162 from $176
🔸 Barclays: Cut to $162 from $176
🔸 Oppenheimer: Reiterates Perform
🔸 Needham: Reiterates Hold
🔸 Roth/MKM: Maintained at Neutral — PT $85
Median Price Target:
— Now: $181 (🔻$6.5)
— Previously: $187.5
Highest Price Target:
— Now: $310
— Previously: $310
Lowest Price Target:
— Now: $85
— Previously: $85
#tsla
